| SC 13D/A | 2021-06-22 | ARMISTICE CAPITAL, LLC | ReShape Weightloss Inc. | 0 | 0.0% | EDGAR |
| SC 13D/A | 2020-09-16 | ARMISTICE CAPITAL, LLC | ReShape Lifesciences Inc. | 12,962,100 | 97.9% | EDGAR |
| SC 13D/A | 2020-08-20 | ARMISTICE CAPITAL, LLC | ReShape Lifesciences Inc. | 11,762,000 | 97.7% | EDGAR |
| SC 13D/A | 2020-04-01 | ARMISTICE CAPITAL, LLC | ReShape Lifesciences Inc. | 11,747,502 | 98.8% | EDGAR |
| SC 13G/A | 2020-02-10 | CVI Investments, Inc. | ReShape Lifesciences Inc. | 10,249 | 2.9% | EDGAR |
| SC 13G/A | 2020-01-21 | SABBY MANAGEMENT, LLC | ReShape Lifesciences Inc. | 106 | 0.0% | EDGAR |
| SC 13D/A | 2019-11-18 | ARMISTICE CAPITAL, LLC | ReShape Lifesciences Inc. | 10,520,207 | 98.4% | EDGAR |
| SC 13G/A | 2019-10-01 | BIGGER CAPITAL FUND L P | ReShape Lifesciences Inc. | 1,729,412 | 9.9% | EDGAR |
| SC 13D/A | 2019-09-30 | ARMISTICE CAPITAL, LLC | ReShape Lifesciences Inc. | 252,630,682 | 92.2% | EDGAR |
| SC 13D | 2019-06-24 | ARMISTICE CAPITAL, LLC | ReShape Lifesciences Inc. | 244,561,824 | 94.9% | EDGAR |
| SC 13G/A | 2019-06-21 | BIGGER CAPITAL FUND L P | ReShape Lifesciences Inc. | 1,070,588 | 9.9% | EDGAR |
| SC 13G | 2019-06-20 | BIGGER CAPITAL FUND L P | ReShape Lifesciences Inc. | 1,070,588 | 9.9% | EDGAR |
| SC 13G/A | 2019-02-14 | CVI Investments, Inc. | ReShape Lifesciences Inc. | 805,771 | 9.9% | EDGAR |
| SC 13G/A | 2019-02-14 | SVLSF IV, LLC | ReShape Lifesciences Inc. | 1,072 | 0.1% | EDGAR |
| SC 13G/A | 2019-02-08 | US VENTURE PARTNERS X LP | ReShape Lifesciences Inc. | 1,458 | 0.0% | EDGAR |
| SC 13G/A | 2019-02-08 | INTRACOASTAL CAPITAL, LLC | ReShape Lifesciences Inc. | 4,765 | 0.1% | EDGAR |
| SC 13G/A | 2019-01-07 | SABBY MANAGEMENT, LLC | ReShape Lifesciences Inc. | 876,156 | 10.0% | EDGAR |
| SC 13G | 2018-12-05 | CVI Investments, Inc. | ReShape Lifesciences Inc. | 811,356 | 9.9% | EDGAR |
| SC 13G/A | 2018-10-12 | Endeavour Medtech Growth L.P. | ReShape Lifesciences Inc. | 228,111 | 0.2% | EDGAR |
| SC 13D/A | 2018-10-05 | HealthCor Partners Management LP | ReShape Lifesciences Inc. | 349,139 | - | EDGAR |